Trials / Not Yet Recruiting
Not Yet RecruitingNCT06514443
Barriers and Faciliators for Physical Activity in People With RMDs
Exploration of Country-specific Barriers and Facilitators for the Implementation of Physical Activity According to the EULAR Physical Activity Recommendations for People With Rheumatic Musculoskeletal Diseases in Four Different European Countries; the COPA Project
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Anne-Kathrin Rausch · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
The aim of this project is to systematically survey and explore barriers and facilitators for the implementation of physical activity according to the physical activity recommendations of the European Alliance of Associations for Rheumatology on country specific (e.g., environmental, cultural, organization and system) level. A questionnaire to explore/identify these barriers and facilitators in the survey, will be developed through literature search, interviews with multiple stakeholders (i.e., patients with inflammatory arthritis or osteoarthritis and physical therapists) and experts in the field in four different European countries (i.e., Turkey, Switzerland, the Netherlands and France). Additionally, in Switzerland only, the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors on personal level, will be translated into the German language. Aim is to evaluate the validity and reliability of the IFAB Questionnaire in the German-speaking population with axial Spondyloarthrits, and to perform a cultural adaptation if necessary at the same time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | survey | survey exploring barriers and faciltiators for physical activity |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2024-12-23
- Completion
- 2025-03-31
- First posted
- 2024-07-23
- Last updated
- 2024-07-23
Source: ClinicalTrials.gov record NCT06514443. Inclusion in this directory is not an endorsement.